ALK and lung cancer: Compared to traditional chemotherapy, such anti‐cancer kinase inhibitors offer improved efficacy, due to their specificity towards individual kinases in tumors.[1] Examples include Ceritinib and Crizotinib, both of which are used in treating anaplastic lymphoma kinase (ALK)‐positive non‐small cell lung cancer.